227 related articles for article (PubMed ID: 25290417)
21. 7th International Immunoglobulin Conference: Immunodeficiencies.
Schmidt RE; Ochs HD
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
[TBL] [Abstract][Full Text] [Related]
22. II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.
Goudouris ES; Rego Silva AM; Ouricuri AL; Grumach AS; Condino-Neto A; Costa-Carvalho BT; Prando CC; Kokron CM; Vasconcelos DM; Tavares FS; Silva Segundo GR; Barreto IC; Dorna MB; Barros MA; Forte WCN
Einstein (Sao Paulo); 2017; 15(1):1-16. PubMed ID: 28444082
[TBL] [Abstract][Full Text] [Related]
23. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
24. The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration.
von Achenbach C; Hevia Hernandez G; von Gunten S
Pharmacology; 2022; 107(11-12):556-563. PubMed ID: 36349790
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulins and their use in children.
Łaguna P; Gołębiowska-Staroszczyk S; Trzaska M; Grabarczyk M; Matysiak M
Adv Clin Exp Med; 2015; 24(1):153-9. PubMed ID: 25923100
[TBL] [Abstract][Full Text] [Related]
26. Managing patients with side effects and adverse events to immunoglobulin therapy.
Azizi G; Abolhassani H; Asgardoon MH; Shaghaghi S; Negahdari B; Mohammadi J; Rezaei N; Aghamohammadi A
Expert Rev Clin Pharmacol; 2016; 9(1):91-102. PubMed ID: 26496172
[TBL] [Abstract][Full Text] [Related]
27. [Prevention and therapy with immunoglobulin SRK].
Schnoz M; Ryser DH; Barandun S; Eckmann L
Helv Chir Acta; 1979 May; 46(1-2):111-3. PubMed ID: 38227
[TBL] [Abstract][Full Text] [Related]
28. [Practical comments on the use of immunoglobulins].
Lewandowicz-Uszyńska A; Swierkot J
Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557
[TBL] [Abstract][Full Text] [Related]
29. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
Berger M; Murphy E; Riley P; Bergman GE;
South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
[TBL] [Abstract][Full Text] [Related]
30. Secondary antibody deficiency.
Duraisingham SS; Buckland MS; Grigoriadou S; Longhurst HJ
Expert Rev Clin Immunol; 2014 May; 10(5):583-91. PubMed ID: 24684706
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.
Wasserman RL
Immunotherapy; 2017 Sep; 9(12):1035-1050. PubMed ID: 28871852
[TBL] [Abstract][Full Text] [Related]
32. [Immunoglobulins in PID, SID and neurological autoimmune disease].
Borte M; Baumann U; Pittrow D; Hensel M; Fasshauer M; Huscher D; Reiser M; Stangel M; Gold R; Kirch W;
Dtsch Med Wochenschr; 2012 Mar; 137(13):675-80. PubMed ID: 22434180
[TBL] [Abstract][Full Text] [Related]
33. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
[TBL] [Abstract][Full Text] [Related]
34. Modern management of primary B-cell immunodeficiencies.
Hoernes M; Seger R; Reichenbach J
Pediatr Allergy Immunol; 2011 Dec; 22(8):758-69. PubMed ID: 22122788
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
36. Switching immunoglobulin products, what are the implications? Result of 2018 census of immunology centres.
Bethune C; Herriot R
Clin Med (Lond); 2019 May; 19(3):201-204. PubMed ID: 31092511
[TBL] [Abstract][Full Text] [Related]
37. 7th International Immunoglobulin Conference: Immunodeficiencies.
Schmidt RE; Ochs HD
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):21. PubMed ID: 25546748
[TBL] [Abstract][Full Text] [Related]
38. 6th International Immunoglobulin Symposium: poster presentations.
Fernandez-Cruz E; Kaveri SV; Peter HH; Durandy A; Cantoni N; Quinti I; Sorensen R; Bussel JB; Danieli MG; Winkelmann A; Bayry J; Käsermann F; Späth P; Helbert M; Salama A; van Schaik IN; Yuki N
Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):60-7. PubMed ID: 19883425
[TBL] [Abstract][Full Text] [Related]
39. [Colombian Guidelines of clinical practice for the use of immunoglobulins in the treatment of replacement and immunomodulation].
Olivares MM; Olmos CE; Álvarez MI; Fajardo AM; Zea-Vera AF; Ortega MC; Medina D; Pérez PM; Beltrán DG; Duque B; Álvarez CA; Lenis G; Solano JM; Gómez D; Franco JL; Díaz MC; Orrego JC; Velásquez MM; Chaparro M; Pinto JL; Izquierdo Á; Ramírez SF
Rev Alerg Mex; 2017; 64 Suppl 2():s5-s65. PubMed ID: 28863425
[TBL] [Abstract][Full Text] [Related]
40. Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases.
Baumann U; Fasshauer M; Pausch C; Wittkowski H; Hermann C; Pittrow D; Borte M
Immunotherapy; 2022 Feb; 14(2):135-143. PubMed ID: 34743590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
